Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosi
Multicenter, Phase Ib/IIa Study on the Safety and Efficacy of Autologous Peptide-coupled Red Blood Cells in Patients with Relapsing Remitting Multiple Sclerosis
What was tested
Treatment tested
- not applicable
What it measured
Main measures
Safety (Part A and B)
Safety
Other measures (1)
Safety endpoints (Part A and B):
Safety
Papers
Loading reviews and guidelines…
History
- In scope changed from true to false
Started
Jan 2023
Assembled by software from public sources.